IL6 and neuroblastoma: These data suggest that neuroblastoma tumors are rich in potentially immunosuppressive cytokines (IL-6 and TGFβ1), but not in cytokines that support NK cell proliferation, differentiation, and activation (IL-2, IL-15, IL-12A, and IL-12B).